Works about ARTIFICIAL pancreases

Results: 712
    1
    2
    3
    4
    5

    Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1582, doi. 10.3390/jcm10081582
    By:
    • de la Rubia Ortí, Jose Enrique;
    • Armero, Jose Luis Platero;
    • Sanchis-Sanchis, Claudia Emmanuela;
    • Sancho-Castillo, Sandra;
    • Salazar, Alejandro;
    • Caplliure-Llopis, Jordi;
    • Navarro-Illana, Esther;
    • Barrios, Carlos;
    • Escribá-Alepuz, Jesús;
    • Benlloch, María
    Publication type:
    Article
    6

    Two Years On.

    Published in:
    Aerospace Medicine & Human Performance, 2021, v. 92, n. 12, p. 927, doi. 10.3357/AMHP.9212PP.2021
    By:
    • DeVoll, James R.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4039, doi. 10.1111/dom.16420
    By:
    • Pleus, Stefan;
    • Eichenlaub, Manuel;
    • Eriksson Boija, Elisabet;
    • Diem, Peter;
    • Fokkert, Marion;
    • Hinzmann, Rolf;
    • Jendle, Johan;
    • Klonoff, David C.;
    • Makris, Konstantinos;
    • Nichols, James H.;
    • Pemberton, John;
    • Selvin, Elizabeth;
    • Slingerland, Robbert J.;
    • Thomas, Andreas;
    • Tran, Nam K.;
    • Witthauer, Lilian;
    • Freckmann, Guido
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 688, doi. 10.1111/dom.14911
    By:
    • Igudesman, Daria;
    • Crandell, Jamie;
    • Corbin, Karen D.;
    • Zaharieva, Dessi P.;
    • Addala, Ananta;
    • Thomas, Joan M.;
    • Casu, Anna;
    • Kirkman, M. Sue;
    • Pokaprakarn, Teeranan;
    • Riddell, Michael C.;
    • Burger, Kyle;
    • Pratley, Richard E.;
    • Kosorok, Michael R.;
    • Maahs, David M.;
    • Mayer‐Davis, Elizabeth J.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Outcomes of hybrid closed‐loop insulin delivery activated 24/7 versus evening and night in free‐living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 511, doi. 10.1111/dom.14605
    By:
    • Renard, Eric;
    • Tubiana‐Rufi, Nadia;
    • Bonnemaison, Elisabeth;
    • Coutant, Régis;
    • Dalla‐Vale, Fabienne;
    • Bismuth, Elise;
    • Faure, Nathalie;
    • Bouhours‐Nouet, Natacha;
    • Farret, Anne;
    • Storey, Caroline;
    • Donzeau, Aurélie;
    • Poidvin, Amélie;
    • Amsellem‐Jager, Jessica;
    • Place, Jérôme;
    • Breton, Marc D.
    Publication type:
    Article
    44
    45
    46

    Alleviating carbohydrate counting with a FiASP‐plus‐pramlintide closed‐loop delivery system (artificial pancreas): Feasibility and pilot studies.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2090, doi. 10.1111/dom.14447
    By:
    • Tsoukas, Michael A.;
    • Cohen, Elisa;
    • Legault, Laurent;
    • von Oettingen, Julia E.;
    • Yale, Jean‐François;
    • Vallis, Michael;
    • Odabassian, Madison;
    • El Fathi, Anas;
    • Rutkowski, Joanna;
    • Jafar, Adnan;
    • Ghanbari, Milad;
    • Gouchie‐Provencher, Nikita;
    • René, Jennifer;
    • Palisaitis, Emilie;
    • Haidar, Ahmad
    Publication type:
    Article
    47

    Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1272, doi. 10.1111/dom.14335
    By:
    • Haidar, Ahmad;
    • Yale, Jean‐Francois;
    • Lovblom, Leif Erik;
    • Cardinez, Nancy;
    • Orszag, Andrej;
    • Falappa, C. Marcelo;
    • Gouchie‐Provencher, Nikita;
    • Tsoukas, Michael A.;
    • El Fathi, Anas;
    • Rene, Jennifer;
    • Eldelekli, Devrim;
    • Lanctôt, Sebastien O.;
    • Scarr, Daniel;
    • Perkins, Bruce A.
    Publication type:
    Article
    48

    Hybrid closed‐loop therapy: Where are we in 2021?

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 655, doi. 10.1111/dom.14273
    By:
    • Leelarathna, Lalantha;
    • Choudhary, Pratik;
    • Wilmot, Emma G.;
    • Lumb, Alistair;
    • Street, Tim;
    • Kar, Partha;
    • Ng, Sze M.
    Publication type:
    Article
    49
    50